SamA Pharmaceutical Co., Ltd   Report issue

For profit Phase 2 Phase 3
Founded: Seoul Korea, Republic of (1945)

Organization Overview

First Clinical Trial
2010
NCT01539304
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

SamA Pharmaceutical Co., Ltd

Active Ingredients

Drugs in Phase 3 Trials (1)

pranlukast (Onon) (2 trials)

Drugs in Phase 2 Trials (1)

Masilukast (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 2)

Rhinitis (Phase 3)

Rhinitis, Allergic (Phase 3)

Rhinitis, Allergic, Perennial (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 2